Bad source data blocks creatine beta-alanine analysis

Key Takeaways

• The cited title and DOI point to a creatine and beta-alanine paper, but the abstract text is for a different non-creatine study.
• Because the primary source content is mismatched, any summary of creatine findings would risk fabricating results.
• The safest editorial choice is to flag the source issue and request the correct abstract or full text.
• Well-established creatine guidance still supports creatine monohydrate as the most-studied form.
• Typical mainstream creatine protocols remain about 3-5 g/day maintenance or roughly 20 g/day split into 4 doses for 5-7 days as a loading option.

The supplied primary source does not support a creatine news article

The news here is not a finding about supplements. It is that the provided source package is internally inconsistent, which makes a trustworthy creatine analysis impossible.

The citation supplied by title and DOI is Effects of combined versus single supplementation of creatine and beta-alanine on aerobic and anerobic performance: a systematic review and network meta-analysis in the Journal of the International Society of Sports Nutrition. But the abstract pasted into the source material is clearly from a different paper entirely: a cardiovascular cohort study on albuminuria, anxiety, depression symptoms, and acute myocardial infarction risk in the Norwegian HUNT study.

Those are not small discrepancies. They mean the core evidence needed to report what the creatine paper actually found is missing. Writing a normal news article anyway would require guessing at methods, sample sizes, outcomes, effect sizes, and limitations. That would violate basic reporting standards.

For readers, the practical implication is simple: do not infer anything about stacking creatine with beta-alanine from the text provided here. If you want broader background on creatine while waiting for the correct study materials, our creatine guides, creatine dosage calculator, and best creatine rankings cover established evidence without speculating about this specific paper.

Why it would be irresponsible to summarise findings anyway

Systematic reviews and network meta-analyses can be influential because they combine multiple studies and may compare interventions indirectly. But that also means their details matter. To report one accurately, you need the real study content: eligibility criteria, number of included trials, participant characteristics, supplement doses, training status, outcome definitions, statistical model, and certainty or risk-of-bias assessments.

None of that can be taken from the pasted abstract, because that abstract is about heart attack risk and mental health symptoms, not sports nutrition. Even the numbers in the source material, such as 11,014 participants and 1,234 incident AMIs over a mean 13.7 years, belong to the wrong paper and cannot be repurposed for a creatine article.

That distinction matters because readers often make supplement decisions from headlines alone. If a site were to claim that combined creatine plus beta-alanine clearly improves aerobic or anaerobic performance based on this mismatched source, it would be inventing evidence. Good journalism means saying “we do not yet have the correct primary-source details” rather than filling the gap with assumptions.

For general evidence-based context on creatine, the strongest long-running consensus still favours creatine monohydrate as the reference form, as outlined in the ISSN position stand and the JISSN review on common questions and misconceptions about creatine.

What we can still say confidently about creatine

Even though this specific paper cannot be summarised from the supplied materials, some points about creatine are well established and do not depend on this missing abstract.

• Creatine monohydrate is the most-studied form. It remains the benchmark for efficacy, safety, availability, and cost-effectiveness.
• A common maintenance dose is 3-5 g/day. Many people can simply take that amount daily.
• Loading is optional. A mainstream approach is about 20 g/day split into 4 doses for 5-7 days, then a lower maintenance intake.
• Consistency matters more than timing for most people. Daily intake is usually the key variable.

Those fundamentals can help readers avoid overreacting to incomplete study coverage. If your goal is to choose a product or routine today, it is more useful to rely on established evidence than on a paper we cannot yet verify. Our creatine product catalog and creatine brand reviews can help you compare options, while the creatine dosage calculator can help you estimate a practical protocol.

What we cannot say, based on the material supplied, is whether this 2026 network meta-analysis found that adding beta-alanine to creatine meaningfully improves sprint performance, endurance measures, repeated-effort output, or any other outcome beyond creatine alone.

How readers should think about creatine plus beta-alanine claims

In practice, stacking claims often sound stronger than the evidence behind them. Creatine and beta-alanine have different proposed roles in performance, so it is plausible that some athletes may use both. But plausibility is not proof of an additive benefit across all outcomes, sports, and populations.

That is exactly why the missing details in the real paper matter. A combined-supplement result can look more impressive or less impressive depending on whether the included studies measured short repeated sprints, time to exhaustion, strength-endurance, or broad “aerobic/anaerobic” composites. It also matters whether participants were trained or untrained, how long supplementation lasted, and whether exercise training was standardised.

Until the correct abstract or full text is available, the best practical approach is conservative:

• Use creatine for evidence-backed reasons, not because you assume every stack is superior.
• Judge products by dose transparency, form, and third-party quality signals, not marketing combinations alone.
• Be cautious with any article that presents precise findings from this paper without showing the actual supplement data.

If the proper study text is provided, this article can be updated into a full analysis of what the network meta-analysis really found, which outcomes were favoured, and how confident readers should be in those estimates.

Bottom line for creatine users right now

The supplied materials do not allow an accurate report on this purported creatine-plus-beta-alanine meta-analysis. The title and DOI indicate one paper, while the abstract belongs to a completely different cardiovascular study. Because of that mismatch, no reliable conclusion about combined versus single supplementation can be drawn from the source provided here.

If you already take creatine, there is no reason from this source package alone to change your routine. The evidence base outside this mismatched citation still supports creatine monohydrate as the best-studied option, commonly taken at 3-5 g/day, with optional loading at roughly 20 g/day split into 4 doses for 5-7 days.

The next step is straightforward: obtain the correct abstract or full text for the cited 2026 JISSN paper. Once that is available, the right questions will be: How many trials were included? What outcomes improved, if any? Were effects clinically meaningful? And did combining beta-alanine with creatine outperform creatine alone, or simply look better than placebo in some settings?

Until then, the most accurate headline is not a supplement claim. It is that the source data currently do not support one.

What can be stated confidently right now

• 3-5 g/day Common creatine maintenance dose — Mainstream evidence-based guidance for creatine monohydrate
• ~20 g/day Typical loading amount — Usually split into 4 daily doses
• 5-7 days Common loading duration — Loading is optional, not required
• 0 Verifiable creatine findings from supplied abstract — The pasted abstract is for an unrelated cardiovascular study

Frequently Asked Questions

Sources & Further Reading

• Kreider et al. (2017), ISSN Position Stand: Safety and Efficacy of Creatine — JISSN
• Antonio et al. (2021), Common questions and misconceptions about creatine supplementation — JISSN